Outlook Therapeutics, Inc. (OTLK)

Price & Market Data

Price: $0.333

Daily Change: $0.00 / 0.00%

Daily Range: $0.282 - $0.369

Market Cap: $37,455,520

Daily Volume: 11,015,036

Performance Metrics

1 Week: 43.63%

1 Month: 16.32%

3 Months: -22.86%

6 Months: -82.16%

1 Year: -78.93%

YTD: -47.39%

About Outlook Therapeutics, Inc. (OTLK)

Stay informed with Outlook Therapeutics, Inc. (OTLK) market data. Current price: 0.333, daily change: $0.00 / 0.00%. Market cap: 37,455,520. Performance over 1-month, 3-month, and 1-year.

Company Details

Employees: 17

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Selected stocks

TechTarget, Inc. (TTGT)

Jiayin Group Inc. (JFIN)

Five Point Holdings, LLC (FPH)

GreenTree Hospitality Group Ltd. (GHG)

VisionSys AI Inc. (VSA)